XM does not provide services to residents of the United States of America.
P
P

Patterson-UTI

News

Energy stocks climb as crude prices spike on fears of widening Middle East tensions

BUZZ-Energy stocks climb as crude prices spike on fears of widening Middle East tensions ** Shares of oil and gas companies climb, tracking higher crude prices; S&P 500 Energy sector .SPNY rises 0.8% ** Brent crude LCoc1 up ~3.5% at $76.46/bbl and U.S. West Texas Intermediate crude CLc1 up ~3.6% at $72.21/bbl on investor concerns that a widening Mi
C
H
P

Factors to watch - Oct 1

MIDEAST - Factors to watch - Oct 1 Here are some factors that may affect Middle East stock markets on Tuesday. Reuters has not verified the press reports and does not vouch for their accuracy. INTERNATIONAL/REGIONAL * GLOBAL MARKETS-Asian stocks ease, dollar firms as traders ponder US rates MKTS/GLOB * Oil little changed as demand worries offset Mi
Q
P

U.S. Aadi Bioscience, Target, Visteon

U.S. RESEARCH ROUNDUP-Aadi Bioscience, Target, Visteon Aug 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aadi Bioscience, Target and Visteon, on Thursday. HIGHLIGHTS * Aadi Bioscience Inc AADI.O : Jefferies cuts to hold from buy * Assurant Inc AIZ.N : Piper Sandler cuts to neutral from overweight * Estée Lauder EL.N : Piper Sandler raises to overweight from neutral * Target Corp TGT.N : Jefferies raises target
A
A
H
S
T
T
U
A
P
U
D
E
A

Patterson-UTI Energy Inc reports results for the quarter ended in June - Earnings Summary

Patterson-UTI Energy Inc reports results for the quarter ended in June - Earnings Summary Patterson-UTI Energy Inc PTEN.OQ reported quarterly adjusted earnings of 3 cents​​ per share for the quarter ended in June, lower than the same quarter last year, when the company reported EPS of 45 cents. The mean expectation of nineteen analysts for the quarter was for earnings of 9 cents per share.
P

Patterson-UTI Energy Q2 Revenue USD 1,300 Million Vs. IBES Estimate USD 1,419 Million

BRIEF-Patterson-UTI Energy Q2 Revenue USD 1,300 Million Vs. IBES Estimate USD 1,419 Million Jul 25 (Reuters) - Patterson-UTI Energy Q2 net income USD 11 million. Q2 EPS USD 0.03 vs. IBES estimate USD 0.09 Q2 dividend USD 0.08
P

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.